BrightSens Diagnostics
Brightsens Diagnostics develops a new generation of molecular diagnostic tests that are simple to use, rapid, and cost-effective, aimed at point-of-care testing for screening, diagnosis, and patient monitoring. Their innovative technology leverages nanoparticle-based fluorescence amplification without enzymatic amplification, suitable for both solid biopsies and liquid samples, and compatible with common laboratory instruments and smartphone applications.
Industries
Nr. of Employees
small (1-50)
Products
miRNA screening and point-of-care assays for oncology
Molecular tests targeting key microRNAs intended for cancer screening, early diagnosis, and patient monitoring in point-of-care or laboratory settings.
Rapid viral RNA detection assays for surveillance
Rapid molecular assays for detection of viral RNA, described for SARS-CoV-2 and variants, designed to offer PCR-comparable sensitivity at lower cost for surveillance and diagnosis.
miRNA screening and point-of-care assays for oncology
Molecular tests targeting key microRNAs intended for cancer screening, early diagnosis, and patient monitoring in point-of-care or laboratory settings.
Rapid viral RNA detection assays for surveillance
Rapid molecular assays for detection of viral RNA, described for SARS-CoV-2 and variants, designed to offer PCR-comparable sensitivity at lower cost for surveillance and diagnosis.
Services
Custom probe design and production
Design and manufacture of nucleic acid probes tailored to customer-specified targets to support R&D and validation workflows.
Partnerships for assay development and validation
Collaborative development with clinical and academic partners to adapt and validate assays for specific clinical applications.
Custom probe design and production
Design and manufacture of nucleic acid probes tailored to customer-specified targets to support R&D and validation workflows.
Partnerships for assay development and validation
Collaborative development with clinical and academic partners to adapt and validate assays for specific clinical applications.
Expertise Areas
- Molecular diagnostics
- Point-of-care testing
- Nanoparticle probe design
- miRNA biomarker assay development
Key Technologies
- Ultrabright fluorescent nanoparticle probes
- FRET-based fluorescence amplification
- Nucleic acid hybridization assays
- miRNA detection assays